Trial NCT03555149

View at ClinicalTrials.gov 
Org. Study IDs: CO39612
Secondary IDs: 2017-004566-99

Last trial update was posted on 2023-11-07

MeSH Interventions

Atezolizumab Bevacizumab

MeSH Conditions

Colorectal Neoplasms

Other Conditions

Colorectal Cancer

Stopping Reasons

The Sponsor made the decision to terminate the study due to start up and recruitment issues caused by limited resource availability at the treating centers.

Limitations And Caveats

This study is not designed to make explicit power and Type I error considerations for a hypothesis test. Instead, this study is designed to obtain preliminary efficacy, safety, and PK data. No formal statistical hypothesis testing was performed in this study. Due to the limited sample size, the results need to be interpreted with caution. For the Atezo+Idasa and Atezo+LOAd703 groups, no meaningful conclusion could be drawn because these experimental arms have been terminated prematurely.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID